Laporan Laba Rugi CPHL - TTM - Citi Pharma Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Citi Pharma Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	5,198	5,795	6,508	8,401	9,369	9,780	10,907	11,110	11,050	12,397	11,980	12,202	13,073	12,409	12,933	13,192	12,974
Change (%)		11.49	12.30	29.09	11.52	4.38	11.52	1.86	-0.53	12.19	-3.36	1.86	7.13	-5.07	4.22	2.00	-1.65
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	4,436	5,024	5,603	7,358	8,148	8,417	9,470	9,552	9,476	10,890	10,597	10,739	11,488	10,823	11,164	11,510	11,275
Change (%)		13.23	11.54	31.32	10.74	3.30	12.51	0.87	-0.80	14.92	-2.69	1.34	6.97	-5.79	3.15	3.09	-2.04
% of Revenue	85.34	86.68	86.09	87.58	86.96	86.06	86.82	85.98	85.75	87.84	88.45	88.01	87.88	87.22	86.33	87.25	86.90

Gross Operating Profit	762	772	905	1,043	1,221	1,363	1,437	1,557	1,574	1,507	1,383	1,463	1,584	1,586	1,768	1,682	1,699
Change (%)		1.32	17.27	15.24	17.08	11.60	5.43	8.36	1.09	-4.26	-8.22	5.79	8.28	0.11	11.48	-4.87	1.02
% of Revenue	14.66	13.32	13.91	12.42	13.04	13.94	13.18	14.02	14.25	12.16	11.55	11.99	12.12	12.78	13.67	12.75	13.10

SG&A	248	201	321	292	312	370	272	275	304	340	339	337	361	381	381	399	407
Change (%)		-18.85	59.55	-8.98	6.98	18.39	-26.50	1.11	10.71	11.68	-0.14	-0.57	6.98	5.49	0.05	4.89	1.89
% of Revenue	4.76	3.47	4.93	3.47	3.33	3.78	2.49	2.47	2.75	2.74	2.83	2.76	2.76	3.07	2.94	3.03	3.14

R&D
Change (%)
% of Revenue

OpEx	4,684	5,224	5,924	7,650	8,460	8,786	9,742	9,827	9,780	11,230	10,936	11,076	11,849	11,204	11,545	11,909	11,682
Change (%)		11.54	13.38	29.14	10.59	3.86	10.87	0.88	-0.48	14.82	-2.61	1.28	6.97	-5.45	3.05	3.15	-1.91
% of Revenue	90.11	90.15	91.02	91.06	90.30	89.84	89.31	88.46	88.51	90.58	91.29	90.77	90.64	90.28	89.27	90.28	90.04

Operating Income	514	571	585	751	909	993	1,165	1,283	1,270	1,167	1,044	1,126	1,224	1,206	1,387	1,283	1,292
Change (%)		11.03	2.39	28.52	21.00	9.27	17.31	10.05	-0.97	-8.08	-10.57	7.86	8.66	-1.47	15.08	-7.54	0.75
% of Revenue	9.89	9.85	8.98	8.94	9.70	10.16	10.69	11.54	11.49	9.42	8.71	9.23	9.36	9.72	10.73	9.72	9.96

Interest Expense	-49	-36	-35	-67	-66	-58	-207	-145	-283	-134	-64	-169	-57	-295	-273	-288	-326
Change (%)		-27.66	-2.38	90.65	-0.76	-12.50	257.70	-29.71	94.89	-52.71	-52.48	166.07	-66.30	418.13	-7.53	5.58	13.07
% of Revenue	-0.95	-0.62	-0.54	-0.79	-0.70	-0.59	-1.89	-1.31	-2.56	-1.08	-0.53	-1.39	-0.44	-2.38	-2.11	-2.19	-2.51

Net Income	296	352	367	542	650	654	718	733	636	658	607	687	806	833	941	822	831
Change (%)		18.93	4.24	47.73	19.99	0.56	9.86	2.13	-13.23	3.39	-7.81	13.31	17.25	3.41	12.84	-12.61	1.10
% of Revenue	5.69	6.07	5.63	6.45	6.94	6.68	6.58	6.60	5.76	5.31	5.06	5.63	6.17	6.72	7.27	6.23	6.40

Source: Capital IQ

Citi Pharma Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)